THEY are arguably the biggest medical breakthrough of recent times. And from this week, so-called ‘fat jabs’ will be made ...

Mounjaro weekly injection is priced at ₹ 4,375 ($50.67) for a 5 mg vial and ₹ 3,500 ($40.54) for a 2.5 mg vial, its lowest doses, the company told new agency Reuters. Its highest dose is 15 mg.

The drug is already widely popular ... Participants in the SURPASS programme achieved average A1C reductions between 1.8% and 2.1% for Mounjaro 5 mg and between 1.7% and 2.4% for both Mounjaro 10 ...

Novo Nordisk sees soaring demand for Ozempic and Wegovy as label expansions and manufacturing boosts fuel obesity market ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for obesity and lifestyle drugs ...

Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...

The Indiana-based drugmaker gained a first-mover advantage in India’s fast-expanding obesity market when it launched Mounjaro 2.5 mg and 5 mg vials at 3,500 rupees ($40.50) and 4,375 rupees ($50 ...

Indian drug companies are preparing to launch low-cost versions of Novo Nordisk’s Wegovy and Ozempic as patents expire in 2026, making weight-loss and diabetes treatment more affordable worldwide.